Sign In
test

Adam Koppel

Bain Capital Life Sciences Investors, Llc

Assets Managed
$1.109B
Holdings
20
Last Quarter
2026 - Q1
Filed Date
7d ago
Growth Rate
-15.07%(2Q avg: -14.2%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Bain Capital Life Sciences Investors, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of Bain Capital Life Sciences Investors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.109B in assets, with a quarterly growth rate of -15.07% and a 2-quarter average growth rate of -14.2%. The portfolio is managed by Adam Koppel, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
HTFL
Heartflow Inc
Recent Activity
Decreased -16.06%
22.93%
$254.204M
10.448M shares@ $24.33 avg price
NAMS
Newamsterdam Pharma Co Nv
Recent Activity
21.1%
$233.883M
7.307M shares@ $32.02 avg price
OLMA
Olema Pharmaceuticals Inc
Recent Activity
Decreased -12.16%
10.05%
$111.426M
7.473M shares@ $14.92 avg price
SVRA
Savara Inc
Recent Activity
8.67%
$96.099M
17.601M shares@ $5.47 avg price
PHVS
Pharvaris Nv
Recent Activity
Decreased -4.51%
6.82%
$75.583M
2.676M shares@ $28.25 avg price
SLDB
Solid Biosciences Inc
Recent Activity
Increased 23.98%
6.37%
$70.623M
9.809M shares@ $7.21 avg price
XFOR
X4 Pharmaceuticals Inc
Recent Activity
2.97%
$32.906M
7.967M shares@ $4.13 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Decreased -51.25%
2.75%
$30.418M
362,470 shares@ $83.92 avg price
ANNX
Annexon Inc
Recent Activity
Decreased -0.69%
2.61%
$28.878M
5.213M shares@ $5.55 avg price
KYTX
Kyverna Therapeutics Inc
Recent Activity
2.43%
$26.839M
3.11M shares@ $8.63 avg price

1-10 of 20